REN and Parkinson disease: The pathway analysis of these metabolites revealed their enrichment in Morphine addiction-related pathways, the cGMP-PKG signaling pathway, the regulation of lipolysis in adipocytes, renin secretion, Parkinson disease-related pathways, and the cAMP signaling pathway (Figure 6A).